Impact of preobesity and obesity on gynecologic diseases

Česká verzia

Authors: Alžbeta Kováčová; Karol Dókuš
Authors place of work: II. gynekologicko–pôrodnícka klinika SZU a FNsP F. D. Roosevelta, Banská Bystrica
Published in the journal: Forum Diab 2023; 12(3): 85-90
Category: Review Article

Summary

According to the World Health Organization (WHO), about 40% of women are preobesity and 15% are obese, which translates into the nature of the health complications that gynecologists and obstetricians currently have to deal with, which require specific management compared to women without obesity.

Keywords:

obesity – malignancy – pregnancy – specific management

Zdroje

World Health Organization [website]. Obesity. Dostupné z WWW: <https://www.who.int/health-topics/obesity#tab=tab_1>.
Obesity Medicine Association. Obesity Algorithm. 2021. Dostupné z WWW: <https://obesitymedicine.org/wp-content/uploads/2021/08/2021-Obesity-Algorithm-PowerPoint.pdf>.
Breitkopf DM. Lateral decubitus position to facilitate pelvic examination of the patient with severe obesity. BMC Woman Health 2021; 21(1): 143. Dostupné z DOI: <https://doi: 10.1186/s12905–021–01289–2>.
National Cancer Institute [website]. Obesity and cancer. Dostupné z WWW: < https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet>.
5.Constantine GD et al. Increased Incidence of Endometrial Cancer Following the Women’s Health Initiative: An Assessment of Risk Factors. J Woman Health (Larchmt) 2019; 28(2): 237–243. Dostupné z DOI: <https://doi: 10.1089/jwh.2018.6956>.
Klopp AH et al. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res 2012; 18(3): 771–782. Dostupné z DOI: <https://doi: 10.1158/1078–0432.CCR-11–1916>.
Onstad MA, Schmandt RE, Lu KH. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. J Clin Oncol 2016; 34(35): 4225–4230. Dostupné z DOI: <https://doi: 10.1200/JCO.2016.69.4638>.
Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 2015; 15(8): 484–498. Dostupné z DOI: <https://doi: 10.1038/nrc3967>.
Klopp AH et al. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res 2012; 18(3): 771–782. Dostupné z DOI: <https://doi: 10.1158/1078–0432.CCR-11–1916>.
McDonald ME, Bender DP. Endometrial Cancer: Obesity, Genetics, and Targeted Agents. Obstet Gynecol Clin North Am 2019; 46(1): 89–105. Dostupné z DOI: <https://doi: 10.1016/j.ogc.2018.09.006>.
11.Ward KK, Shah NR, Saenz CC et al. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol 2012; 126(2): 176–179. Dostupné z DOI: <https://doi: 10.1016/j.ygyno.2012.04.013>.
McCullough ML, Patel AV, Patel R et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev 2008; 17(1): 73–79. Dostupné z DOI: <https://doi: 10.1158/1055–9965>.
ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005; 106(2): 413–425. Dostupné z DOI: <https://doi: 10.1097/00006250–200508000–00050>.
Avgerinos KI, Spyrou N , 1Christos S Mantzoros CS et al. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism 2019; 92:121–135. Dostupné z DOI: <https://doi: 10.1016/j.metabol.2018.11.001>.
Colleluori G, Perugini J, Barbatelli G et al. Mammary gland adipocytes in lactation cycle, obesity and breast cancer. Rev Endocr Metab Disord 2021; 22(2): 241–255. Dostupné z DOI: <https://doi: 10.1007/s11154–021–09633–5>.
Haakinson DJ, Leeds SG, Dueck AC et al. The Impact of Obesity on Breast Cancer: a retrospective review. Ann Surg Oncol 2012; 19(9): 3012–3018. Dostupné z DOI: <https://doi: 10.1245/s10434–012–2320–8>.
Petrelli F, Cortellini A, Indini A et al. Association of obesity with survival outcomes in patients with cancer: A systematic review and meta-analysis. JAMA Netw Open 2021; 4(3): e213520. Dostupné z DOI: <https://doi: 10.1001/jamanetworkopen.2021.3520>.
Ewertz M, Jensen MB, Gunnarsdóttir KA et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 2011; 29(1): 25–31. Dostupné z DOI: <https://doi: 10.1200/JCO.2010.29.7614>.
Buono, G, Crispo A, Giuliano M et al. Metabolic syndrome and early stage breast cancer outcome: Results from a prospective observational study. Breast Cancer Res Treat 2020; 182(2): 401–409. Dostupné z DOI: <https://doi: 10.1007/s10549–020–05701–7>.
Women’s Preventive Services Initiative. Recommendations forwell-woman care clinical summary tables. Updated January 11, 2022. Dostupné z WWW: <https://www.womenspreventivehealth.org/wp-content/uploads/FINAL_WPSI_ClinicalSummaryTables_2022.pdf>.
Perou CM. Molecular stratification of triple-negative breast cancers. The Oncologist 2010; 15(S5): 39–48. Dostupné z DOI: <https://doi: 10.1634/theoncologist.2010-S5–39>.
Olsen CM, Green AC, Whiteman DC et al. Obesity and the Risk of Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis. Eur J Cancer 2007; 43(4): 690–709. Dostupné z DOI: <https://doi: 10.1016/j.ejca.2006.11.010>.
Smits A, Lopes A, Das N et al. Surgical Morbidity and Clinical Outcomes in Ovarian Cancer – The Role of Obesity. BJOG 2016; 123(2): 300–308. Dostupné z DOI: <https://doi: 10.1111/1471–0528.13585>.
Protani MM, Nagle CM, Webb PM. Obesity and ovarian cancer survival: a systematic review and meta-analysis. Cancer Prev Res 2012; 5: 901–910. Dostupné z DOI: <https://doi: 10.1158/1940–6207.CAPR-12–0048>.
Lacey JV, jr, Swanson CA, Brinton LA et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003; 98: 814–821. Dostupné z DOI: <https://doi: 10.1002/cncr.11567>.
Santos S, Voerman E, Amiano P et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts. BJOG 2019; 126(8): 984–995. Dostupné z DOI: <https://doi: 10.1111/1471–0528.15661>.
Gaillard R. Maternal obesity during pregnancy and cardiovascular development and disease in the offspring. Eur J Epidemiol 2015; 30(11): 1141–1152. Dostupné z DOI: <https://doi: 10.1007/s10654–015–0085–7>.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins Obstetrics. Obesity in Pregnancy: ACOG Practice Bulletin, Number 230. Obstet Gynecol 2021; 137(6): e128-e144. Dostupné z DOI: <https://doi: 10.1097/AOG.0000000000004395>.
Fleming TP, Watkins AJ, Velazquez MA et al. Origins of life-time health around the time of conception: causes and consequences. Lancet 2018; 391(10132): 1842–1852. Dostupné z DOI: <https://doi: 10.1016/S0140–6736(18)30312-X>.
Best KE, Tennant PW, Bell R et al. Impact of maternal body mass index on the antenatal detection of congenital anomalies. BJOG 2012; 119(12): 1503–1511. Dostupné z DOI: <https://doi: 10.1111/j.1471–0528.2012.03462.x>.
Park J, Morley TS, Kim M et al. Obesity and cancer--mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 2014; 10(8): 455–465. Dostupné z DOI: <https://doi: 10.1038/nrendo.2014.94>.
Crafts TD, Tonneson JE, Wolfe BM et al. Obesity and breast cancer: preventive and therapeutic possibilities for bariatric surgery. Obesity (Silver Spring) 2022; 30(3): 587–598. Dostupné z DOI: <https://doi:10.1002/oby.23369>.
Fábryová Ľ (ed) et al. Klinická obezitológia. Facta Medica: Brno 2023. ISBN 978–80–88056–16–4.